CFTR and autoimmune disease: Although histological changes of the pancreas related to ETI treatment are not yet defined in humans, improved acinar structure, correction of ductal CFTR activity has been shown to reduce ductal obstruction and inflammatory infiltration in animal model of autoimmune disease (35).